Show simple item record

dc.contributor.authorLai, Austinen
dc.date.accessioned2021-05-10T23:31:50Z
dc.date.available2021-05-10T23:31:50Z
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/322243
dc.description.abstractAn estimated 400 million individuals suffer from rare diseases globally. Tackling rare diseases has historically posed difficulties, including the lack of knowledge about their underlying causes, lack of resources for patients, and fundamental inefficiencies at multiple stages along the pipeline, from basic science discovery to clinical translation and diagnosis. The development of rare disorder therapeutics, often termed orphan drugs, faces a unique set of challenges in clinical trials: difficulties in recruiting patients, difficulties in following conventional clinical trial structure, as well as financial barriers for drug approval. Here, I argue for the creation of an international organisation for rare diseases to coordinate a shared global patient registry and standard for orphan drug approval. An initiative of such nature, with representation from experts and organisations in the science, medicine, and patient-support industries will assist in overcoming the present challenges, whilst accelerating progress and improving the experience during treatment of patients with rare disorders.
dc.publisherCUSPE (Cambridge University Science and Policy Exchange)
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectRare diseasesen
dc.subjectOrphan drugsen
dc.subjectInternational organisationsen
dc.subjectScience Policyen
dc.subjectGrantsen
dc.titleReimagining rare disease policies through a global lensen
dc.typeArticle
prism.issueIdentifier1en
prism.publicationNameCambridge Journal of Science and Policyen
prism.volume2en
dc.identifier.doi10.17863/CAM.69702
pubs.declined2021-05-09T20:13:10.756+0100
dcterms.dateAccepted2021-05-06en
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/en
rioxxterms.licenseref.startdate2021-05-06en
rioxxterms.typeJournal Article/Reviewen
cam.issuedOnline2021-05-09en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International